Viz RV/LV vs Zio AT ECG Monitoring System
AI Verdict
Choose Viz RV/LV if…
Choose Viz RV/LV if your priority is rapid, AI-driven risk stratification for suspected pulmonary embolism (PE) based on CTPA scans. This tool is ideal for emergency medicine and radiology departments needing automated right-to-left ventricular ratio measurements to quickly assess PE severity and facilitate immediate care team coordination for critical patients.
View Viz RV/LV →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if you require continuous, long-term (up to 14 days) ECG monitoring for the detection of symptomatic and asymptomatic cardiac arrhythmias. This wearable solution is best suited for cardiologists seeking comprehensive, AI-powered analysis to diagnose intermittent heart rhythm disorders that may not be captured during shorter monitoring periods.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz RV/LV | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | Cloud-based (data analytics and clinician portal) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV streamlines acute care workflows for clinicians by providing rapid AI-powered insights, a high-fidelity mobile DICOM image viewer, and an integrated communication platform within existing hospital systems. Its focus on immediate, critical decision-making and high reported engagement rates demonstrate strong usability for healthcare providers in time-sensitive situations.
Clinical Value
TieBoth tools offer significant and well-documented clinical value in their respective domains. Viz RV/LV provides rapid, potentially life-saving insights for acute pulmonary embolism management by drastically reducing time to diagnosis and treatment. Zio AT offers superior long-term arrhythmia detection compared to traditional methods, leading to higher diagnostic yields and fewer repeat tests, which is crucial for managing chronic cardiac conditions.
Pricing & Value
TieBoth Viz RV/LV and Zio AT have non-public pricing, making a direct comparison of their costs and value propositions impossible. While both demonstrate clinical benefits that can lead to cost savings and improved outcomes, specific return on investment figures or transparent pricing models are not available for either tool.
Enterprise Readiness
Viz RV/LVViz RV/LV, as part of the Viz.ai One platform, demonstrates superior enterprise readiness with its adoption in nearly 2,000 hospitals, including major health systems, and its deep integration capabilities with existing PACS, EHR, and cloud environments. Its collaboration with Microsoft and offering of over 50 AI models across multiple specialties highlight a comprehensive, scalable, and interoperable enterprise solution.
Innovation
Zio AT ECG Monitoring SystemZio AT's innovation lies in its novel wearable, patch-based form factor for continuous, long-term ECG monitoring, combined with a deep-learned AI algorithm for comprehensive arrhythmia detection. This approach significantly improves diagnostic yield over traditional methods and offers a more patient-friendly and diagnostically superior solution for detecting intermittent cardiac events.
Support & Docs
Viz RV/LVViz.ai provides a robust support and documentation ecosystem, including a 'Viz Academy' for comprehensive clinician-led product training and clinical education, a dedicated customer success team, and clinical and workflow specialists. This structured and extensive approach to support and education is more explicitly detailed than the information available for Zio AT.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz RV/LV | Zio AT ECG Monitoring System |
|---|---|---|
| Tool Name | Viz RV/LV | Zio AT ECG Monitoring System |
| Company | Viz.ai | iRhythm Technologies, Inc. |
| Primary Function | FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Key AI Application | AI algorithm for identification and measurement of heart ventricles and RV/LV ratio. | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection. |
| Target Specialties | Emergency Medicine, Pulmonology, Radiology | Cardiology |
| Core Output/Measurement | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; annotated images showing ventricular measurements. | Continuous, uninterrupted ECG recording for up to 14 days; detection of symptomatic and asymptomatic cardiac events; comprehensive end-of-wear reports. |
Videos
Demos, reviews, and walkthroughs featuring Viz RV/LV and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz RV/LV or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.